Issue 39, 2025

A conjugated molecule based on tetra-fused thienoisoindigo ribbon for NIR-II photothermal cancer therapy

Abstract

Water-soluble nanoparticles (NPs) based on the well-defined 4ThIID molecules, namely 4ThIID NPs, were prepared. Benefiting from the strong NIR-II absorption and high photothermal conversion properties of 4ThIID, the ε1064 × PTCE1064 value of 4ThIID NPs reaches 9.18 × 104, which is the highest value among the reported NIR-II photothermal small molecules. In vivo experiments show that 4ThIID NPs can effectively inhibit the growth of tumors in mouse models under the irradiation of a 1064 nm laser.

Graphical abstract: A conjugated molecule based on tetra-fused thienoisoindigo ribbon for NIR-II photothermal cancer therapy

Supplementary files

Article information

Article type
Communication
Submitted
27 Mar 2025
Accepted
10 Apr 2025
First published
11 Apr 2025

Chem. Commun., 2025,61, 7129-7132

A conjugated molecule based on tetra-fused thienoisoindigo ribbon for NIR-II photothermal cancer therapy

J. Chen, J. Wu, H. Chen, Y. Zhu, Y. Zong, Y. Gao, X. Zheng and Y. Jiang, Chem. Commun., 2025, 61, 7129 DOI: 10.1039/D5CC01712B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements